Ukrainian government eases access of imported drugs to domestic market

The Ukraine government plans to ease access to imported drugs to the domestic market, through the reduction of the time for registration of the newly-launched drugs from the current 30 to 10 days.

This should significantly speed the launch of new drugs in the Ukranian pharmaceutical market and will result in the reduction of costs for producers.

The new initiative has already been approved by Vladimir Groisman, the newly-appointed Prime Minister of Ukraine, according to which implementation of these plans will allow the significant reduction in the level of bureaucratization of the Ukranian pharmaceutical market.

According to Mr Groisman, the Ukranian government will continue to implement measures, aimed at easing an access of global drugmakers to the country’s pharmaceutical market.